Sight Diagnostics uses advanced computer-vision and machine-learning technology in the field of blood diagnostics. The company’s initial product, the Parasight platform, is a highly accurate, easy-to-use device for diagnosing malaria.

Sight Diagnostics is also applying its technology to the complete blood count (CBC) market, developing a point-of-care CBC platform which will provide a five-point differential blood count for use in doctors’ offices and emergency medical centers.